Résultats de la recherche - 7 results

Clinical performance of the novel full-genotyping OncoPredict HPV Quantitative Typing assay using the VALGENT framework.

Infections Reproducibility of Results Sensitivity and Specificity Uterine Cervical Dysplasia Uterine Cervical Neoplasms Young adult Abstract: Clinical validation of human papillomavirus (HPV) assays according ...

Can REALQUALITY RQ-HPV screen be considered as a clinically validated HPV test for use in cervical cancer screening?

Detection of Cancer Female Humans Mass Screening Papillomaviridae Papillomavirus Infections Uterine Cervical Dysplasia Uterine Cervical Neoplasms Vaginal Smears Abstract: “Can REALQUALITY RQ- HPV screen be ...

HPV-based Cervical Cancer Screening on Self-samples in the Netherlands: Challenges to Reach Women and Test Performance Questions.

Uterine Cervical Neoplasms Abstract: In 2017, cervical cancer screening in the Netherlands switched from cytology to human papillomavirus (HPV) testing using the validated PCR-based cobas 4800. Women could ...

Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors.

Volume 13 (2022) Keywords: BNT162 Vaccine COVID-19 Cytokines Female Humans Intercellular Signaling Peptides and Proteins Neoplasms Placenta Growth Factor vaccines Abstract: BACKGROUND: Patients with ...

Antibody titres before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients with cancer.

Viral Biomarkers BNT162 Vaccine COVID-19 Vaccines Humans Immunity, Humoral Immunization Schedule Immunization, Secondary Immunogenicity, Vaccine Neoplasms Prospective Studies Risk Factors Time Factors ...

Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment.

5 (2021) Keywords: Antineoplastic Agents BNT162 Vaccine COVID-19 COVID-19 Vaccines Humans Immunity, Humoral Neoplasms Prospective Studies RNA, Messenger SARS-CoV-2 Vaccination Abstract: BACKGROUND: Cancer ...

HPV DNA genotyping, HPV E6*I mRNA detection, and p16INK4a/Ki-67 staining in Belgian head and neck cancer patient specimens, collected within the HPV-AHEAD study

80 and over Alphapapillomavirus Belgium Cyclin-Dependent Kinase Inhibitor p16 DNA, Viral Female Genotype Head and Neck Neoplasms Head and neck neoplasms; Human papillomavirus; Human papillomavirus DNA ...

QR code

QR code for this page URL